The 3rd of November, Eevia Health (“Eevia” or “the company”) announced that the company has developed a new plant extract with product benefits for cognitive health and improved sleep. The new ingredient product, Feno-Cerasus™, is a standardized anthocyanin extract from tart cherry (Prunus Cerasus). Eevia Health focuses on the cognitive effects, including sleep quality and quantity, memory, as well as stress, and cortisol levels.
About Analyst Group: One of Sweden's leading equity analysis houses with a focus on small and medium-sized listed companies.
Read more about Analyst Group
This is a press release from Analyst Group regarding the publication of comments on Eeevia Health. Readers may assume that Analyst Group has received compensation for making the commentary. The Company has not been given an opportunity to influence the parts where Analyst Group has had opinions about the Company, future valuation or anything else that could be considered a subjective assessment.